Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.
Sign Up to like & getrecommendations! Published in 2019 at "Current Opinion in Hematology"
DOI: 10.1097/moh.0000000000000558
Abstract: PURPOSE OF REVIEW Registries provide 'real world' perspectives on the natural history and outcomes for many clinical conditions. The purpose of this review is to identify registries for nonmalignant hematological disease and to describe the… read more here.
Keywords: severe chronic; nonmalignant hematological; registry; international registry ... See more keywords
Severe Chronic Neutropenia in the Large Granular Lymphocyte Syndrome: Outcomes in Response to Granulocyte Colony Stimulating Factor (G-CSF) and Immunosuppressive Therapies
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-126181
Abstract: The large granular lymphocyte (LGL) syndrome and large granular lymphocytic leukemia (LGLL) are rare hematological disorders. Through the Severe Chronic Neutropenia International Registry (SCNIR) we have followed the clinical course and treatment responses of 27… read more here.
Keywords: chronic neutropenia; csf; severe chronic; consultancy ... See more keywords
Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021005684
Abstract: Key Points G-CSF is an effective long-term therapy for SCN with a wide range of effective doses requiring individualized dose titration. Eleven percent of patients with CN developed MDS/AML; patients with autoimmune/idiopathic neutropenia did not… read more here.
Keywords: outcomes patients; severe chronic; chronic neutropenia; patients severe ... See more keywords
Dealing with pre-existing chronic neutropenia in cancer patients—considerations and consequences in the clinical praxis
Sign Up to like & getrecommendations! Published in 2020 at "ecancermedicalscience"
DOI: 10.3332/ecancer.2020.1131
Abstract: Chronic neutropenia is a rare but important challenge with substantial clinical implications for patients receiving antineoplastic treatment. Treatment-induced neutropenia is a well-known adverse event during chemotherapy and some targeted treatments. Guidelines for administering chemotherapy are… read more here.
Keywords: chronic neutropenia; pre existing; dealing pre; antineoplastic treatment ... See more keywords